Infliximab-induced Demyelination Causes Visual Disturbance Mistaken for Recurrence of HLA-B27-related Uveitis

Authors: Papadia, Marina; Herbort, Carl Peter

Source: Ocular Immunology and Inflammation, Volume 18, Number 6, December 2010 , pp. 482-484(3)

Publisher: Informa Healthcare

Buy & download fulltext article:

The full text article is not available for purchase.

The publisher only permits individual articles to be downloaded by subscribers.

Abstract:

Purpose: To report a patient treated with infliximab for ankylosing spondylitis and HLA-B27 uveitis presenting with a scotoma in his left good eye due to infliximab-induced occipital demyelination mistaken for a uveitis recurrence.

Design: Case report.

Methods: Review of clinical features, visual field, and investigational procedures.

Results: Loss of visual function could not be explained by mere ophthalmic examination. Magnetic resonance imaging showed several demyelinating lesions, explaining the patient's symptoms and signs. Infiliximab was discontinued and the scotoma disappeared.

Conclusion: This is the first report of infliximab-induced demyelination producing ocular symptoms and signs in a patient treated for uveitis.
More about this publication?
Related content

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page